...
首页> 外文期刊>Analytica chimica acta >Supercritical fluid chromatographic method using phenyl packed column for determination of phenobarbitone and phenytoin sodium in dosage form
【24h】

Supercritical fluid chromatographic method using phenyl packed column for determination of phenobarbitone and phenytoin sodium in dosage form

机译:苯填充柱超临界流体色谱法测定剂型中苯巴比妥和苯妥英钠

获取原文
获取原文并翻译 | 示例
           

摘要

The separation and estimation of phenobarbitone and phenytoin sodium in pharmaceutical dosage form, using chromatography with methanol-modified supercritical fluid CO2 has been investigated with carbamazepine as the internal standard. The analytes were resolved using a Shendon-Phenyl 5 mu m (250x4.6 mm) column, using 11.8% methanol in CO2 (1.5 mi min(-1)) as mobile phase and detection at 230 nm. The phenyl column showed the most favourable chromatographic parameters for analysis. The densities and polarities of the mobile phase were optimised for the effects of pressure, temperature and modifier concentration on the retention time. The study includes a successful attempt at quantification of the drugs. Chromatographic figures of merit, calibration data, and recovery of the drugs from spiked concentrations were determined to assess the viability of the method. Limits of detection (3 x standard deviation) of the assay were 0.40 mu g ml(-1) for phenobarbitone and 0.20 mu g ml(-1) for phenytoin sodium. The method has been successfully used to analyse commercial solid dosage form of locally available tablets labelled to contain 30/50 mg of phenytoin sodium and 50 mg of phenobarbitone with good recoveries. The internal standard method using carbamazepine has been employed to estimate the drug content of the tablets. There was no interference from excipients. (C) 1999 Elsevier Science B.V. All rights reserved. [References: 7]
机译:以卡马西平为内标,采用甲醇改性的超临界流体CO2色谱法分离并估算了药物剂型中的苯巴比妥和苯妥英钠。使用Shendon-Phenyl 5μm(250x4.6 mm)色谱柱,在CO2中的11.8%甲醇(1.5 mi min(-1))作为流动相和在230 nm处检测,分离分析物。苯基柱显示出最有利的色谱分析参数。针对压力,温度和改性剂浓度对保留时间的影响,优化了流动相的密度和极性。该研究包括成功定量药物的尝试。测定色谱图的优劣,校正数据和从加标浓度中回收的药物,以评估该方法的可行性。测定的检出限(3 x标准偏差)为苯巴比妥为0.40μg ml(-1),苯妥英钠为0.20μg ml(-1)。该方法已成功地用于分析标记为包含30/50 mg苯妥英钠和50 mg苯巴比妥的本地可购片剂的商业固体剂型,回收率良好。使用卡马西平的内标方法已被用来估计片剂的药物含量。没有辅料的干扰。 (C)1999 Elsevier Science B.V.保留所有权利。 [参考:7]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号